JP2012504608A5 - - Google Patents

Download PDF

Info

Publication number
JP2012504608A5
JP2012504608A5 JP2011530057A JP2011530057A JP2012504608A5 JP 2012504608 A5 JP2012504608 A5 JP 2012504608A5 JP 2011530057 A JP2011530057 A JP 2011530057A JP 2011530057 A JP2011530057 A JP 2011530057A JP 2012504608 A5 JP2012504608 A5 JP 2012504608A5
Authority
JP
Japan
Prior art keywords
group
substituted
pharmaceutical composition
halogen
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011530057A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012504608A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/005435 external-priority patent/WO2010039256A1/en
Publication of JP2012504608A publication Critical patent/JP2012504608A/ja
Publication of JP2012504608A5 publication Critical patent/JP2012504608A5/ja
Withdrawn legal-status Critical Current

Links

JP2011530057A 2008-10-03 2009-10-02 ２−アシルアミノプロパノール−タイプグルコシルセラミドシンターゼ抑制剤 Withdrawn JP2012504608A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10254108P 2008-10-03 2008-10-03
US61/102,541 2008-10-03
PCT/US2009/005435 WO2010039256A1 (en) 2008-10-03 2009-10-02 2-acylaminopropoanol-type glucosylceramide synthase inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015075248A Division JP6175465B2 (ja) 2008-10-03 2015-04-01 ２−アシルアミノプロパノール−タイプグルコシルセラミドシンターゼ抑制剤

Publications (2)

Publication Number Publication Date
JP2012504608A JP2012504608A (ja) 2012-02-23
JP2012504608A5 true JP2012504608A5 (enExample) 2012-10-25

Family

ID=41402426

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2011530057A Withdrawn JP2012504608A (ja) 2008-10-03 2009-10-02 ２−アシルアミノプロパノール−タイプグルコシルセラミドシンターゼ抑制剤
JP2015075248A Expired - Fee Related JP6175465B2 (ja) 2008-10-03 2015-04-01 ２−アシルアミノプロパノール−タイプグルコシルセラミドシンターゼ抑制剤
JP2017095022A Expired - Fee Related JP6297194B2 (ja) 2008-10-03 2017-05-11 ２−アシルアミノプロパノール−タイプグルコシルセラミドシンターゼ抑制剤
JP2018028160A Pending JP2018087232A (ja) 2008-10-03 2018-02-20 ２−アシルアミノプロパノール−タイプグルコシルセラミドシンターゼ抑制剤

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2015075248A Expired - Fee Related JP6175465B2 (ja) 2008-10-03 2015-04-01 ２−アシルアミノプロパノール−タイプグルコシルセラミドシンターゼ抑制剤
JP2017095022A Expired - Fee Related JP6297194B2 (ja) 2008-10-03 2017-05-11 ２−アシルアミノプロパノール−タイプグルコシルセラミドシンターゼ抑制剤
JP2018028160A Pending JP2018087232A (ja) 2008-10-03 2018-02-20 ２−アシルアミノプロパノール−タイプグルコシルセラミドシンターゼ抑制剤

Country Status (10)

Country Link
US (3) US8309593B2 (enExample)
EP (2) EP2349255B1 (enExample)
JP (4) JP2012504608A (enExample)
KR (1) KR101687039B1 (enExample)
CN (2) CN102271678B (enExample)
CA (1) CA2738768C (enExample)
IL (2) IL211946A (enExample)
MX (1) MX2011003517A (enExample)
RU (1) RU2578947C2 (enExample)
WO (1) WO2010039256A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006053043A2 (en) 2004-11-10 2006-05-18 Genzyme Corporation Methods of treating diabetes mellitus
PT2032134E (pt) * 2006-05-09 2015-10-07 Genzyme Corp Métodos de tratamento da doença do fígado gorduroso
EP2594565B1 (en) 2007-05-31 2018-10-24 Genzyme Corporation 2-acylaminopropanol-type glucosylceramide synthase inhibitors
ES2660690T3 (es) * 2007-10-05 2018-03-23 Genzyme Corporation Método para tratar poliquistosis renales con derivados de ceramida
JP2011529500A (ja) 2008-07-28 2011-12-08 ジェンザイム コーポレーション 虚脱性糸球体症および他の糸球体疾患の処置のためのグルコシルセラミドシンターゼ阻害
CA2738768C (en) 2008-10-03 2017-10-31 Genzyme Corporation 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
US8961959B2 (en) 2011-10-17 2015-02-24 The Regents Of The University Of Michigan Glucosylceramide synthase inhibitors and therapeutic methods using the same
CN102702010B (zh) * 2012-05-23 2014-09-17 北京大学 光敏感的功能化固载相及其制备方法和应用
WO2014150043A1 (en) * 2013-03-15 2014-09-25 Concert Pharmaceuticals Inc. Inhibitors of the enzyme udp-glucose: n-acyl-sphingosine glucosyltransferase
CN105745206B (zh) 2013-09-20 2019-08-13 生物马林药物股份有限公司 用于治疗疾病的葡萄糖神经酰胺合成酶抑制剂
CA2954030A1 (en) * 2014-07-03 2016-01-07 Dr. Reddy's Laboratories Limited Amorphous form of eliglustat hemitartarate
US10202340B2 (en) 2015-02-02 2019-02-12 The Regents Of The University Of Michigan Glucosylceramide synthase inhibitors and therapeutic methods using the same
CN107635980A (zh) * 2015-03-11 2018-01-26 生物马林药物股份有限公司 用于治疗疾病的葡糖神经酰胺合酶抑制剂
US11116755B2 (en) 2015-11-18 2021-09-14 Genzyme Corporation Biomarker of polycystic kidney disease and uses thereof
MA44484A (fr) 2016-03-25 2019-01-30 Genzyme Corp Biomarqueurs de protéinopathies et utilisations associées
WO2017204319A1 (ja) * 2016-05-27 2017-11-30 公益財団法人野口研究所 グルコシルセラミド合成酵素阻害剤
JP2021506920A (ja) 2017-12-21 2021-02-22 リソソーマル・セラピューティクス・インコーポレイテッドＬｙｓｏｓｏｍａｌ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 結晶性の置換シクロヘキシルピラゾロ［１，５−ａ］ピリミジニルカルボキサミド化合物およびその治療的使用

Family Cites Families (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1555654A (en) * 1977-06-25 1979-11-14 Exxon Research Engineering Co Agricultural burner apparatus
US4065562A (en) * 1975-12-29 1977-12-27 Nippon Shinyaku Co., Ltd. Method and composition for reducing blood glucose levels
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
GB2020278B (en) * 1978-05-03 1983-02-23 Nippon Shinyaku Co Ltd Moranoline dervitives
JPS568318A (en) 1979-06-28 1981-01-28 Janssen Pharmaceutica Nv Non oral long acting composition of haloperidol and bromperidol derivative
GB8311286D0 (en) 1983-04-26 1983-06-02 Searle & Co Carboxyalkyl peptide derivatives
EP0144290A3 (de) * 1983-12-01 1987-05-27 Ciba-Geigy Ag Substituierte Aethylendiaminderivate
US5041441A (en) * 1988-04-04 1991-08-20 The Regents Of The University Of Michigan Method of chemotherapy using 1-phenyl-2-decanoylamino-3-morpholino-1-propanol
JPH0416856A (ja) 1990-05-10 1992-01-21 Canon Inc 正帯電性非磁性トナー
JPH04140984A (ja) 1990-10-02 1992-05-14 Canon Inc スチルビデオカメラ
RU2005102C1 (ru) * 1991-06-21 1993-12-30 Институт геологии Карельского научного центра РАН Способ получени декоративного стекла
US5302609A (en) 1992-12-16 1994-04-12 The Regents Of The University Of Michigan Treatment of diabetic nephropathy
US5399567A (en) * 1993-05-13 1995-03-21 Monsanto Company Method of treating cholera
WO1995005177A1 (en) 1993-08-13 1995-02-23 Seikagaku Corporation Remedy for nervous diseases
PT742789E (pt) * 1994-02-02 2000-12-29 Liposome Co Inc Lipossomas e compostos farmaceuticamente activos e metodos para a sua utilizacao
DE69524592T2 (de) 1994-06-10 2002-07-18 Seikagaku Corp., Tokio/Tokyo 2-Acylaminopropanolverbindung und ihre pharmazeutische Zusammensetzung
WO1997010817A1 (en) * 1995-09-20 1997-03-27 The Regents Of The University Of Michigan Amino ceramide-like compounds and therapeutic methods of use
US6255336B1 (en) * 1995-09-20 2001-07-03 The Regents Of The University Of Michigan Amino ceramide-like compounds and therapeutic methods of use
WO2001004108A1 (en) 1999-07-09 2001-01-18 Regents Of The University Of Michigan Amino ceramide-like compounds and therapeutic methods of use
US20030073680A1 (en) * 1995-09-20 2003-04-17 The Regents Of The University Of Michigan Amino ceramide-like compounds and therapeutic methods of use
JP3993908B2 (ja) 1995-12-08 2007-10-17 生化学工業株式会社 アミノアルコール誘導体及び該誘導体の製造方法
NO965193L (no) * 1995-12-08 1997-06-09 Seikagaku Kogyo Kk Seikagaku C Aminalkoholderivat og fremgangsmåte for fremstilling derav
JP4140984B2 (ja) 1995-12-20 2008-08-27 生化学工業株式会社 分化誘導作用を有する薬剤
US5972928A (en) * 1997-05-21 1999-10-26 Johns Hopkins University Methods for treatment of conditions associated with lactosylceramide
JP4036500B2 (ja) 1997-05-23 2008-01-23 生化学工業株式会社 アミノアルコール誘導体及びそれを含有する医薬
JP4176170B2 (ja) 1997-06-06 2008-11-05 生化学工業株式会社 アミノアルコール誘導体を含む医薬及び異常増殖性疾患治療薬
US6465488B1 (en) * 1997-12-11 2002-10-15 Chancellor, Masters & Scholars Of The University Of Oxford Inhibition of glycolipid biosynthesis
ES2285852T3 (es) * 1998-07-27 2007-11-16 Johns Hopkins University Compuestos de diamino-propanol para el tratamiento de la isquemia.
US6610703B1 (en) * 1998-12-10 2003-08-26 G.D. Searle & Co. Method for treatment of glycolipid storage diseases
GB0100889D0 (en) * 2001-01-12 2001-02-21 Oxford Glycosciences Uk Ltd Compounds
MXPA02000296A (es) * 1999-07-09 2004-05-21 Univ Michigan Compuestos parecidos a aminoceramida y metodos de uso.
EP1384719A1 (en) 1999-07-09 2004-01-28 The Regents of The University of Michigan Inhibitors of the glucosyl ceramide synthase enzyme useful for the treatment of cancers, sphingolipidosis and microbial infections
JP5009459B2 (ja) * 1999-12-06 2012-08-22 生化学工業株式会社 アミノアルコール誘導体及びそれを含有する医薬
US6407064B2 (en) * 1999-12-06 2002-06-18 Seikagaku Corporation Aminoalcohol derivative and medicament comprising the same
US6235737B1 (en) 2000-01-25 2001-05-22 Peter Styczynski Reduction of hair growth
CA2406067A1 (en) 2000-04-19 2001-11-01 Thomas Julius Borody Compositions comprising the combination of a bile acid and a fibrate for use in therapies for hyperlipidaemia-associated disorders
CA2432908A1 (en) 2000-12-20 2002-06-27 Bristol-Myers Squibb Pharma Company Diamines as modulators of chemokine receptor activity
WO2002053528A1 (en) 2000-12-29 2002-07-11 Wyeth Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines
US20040260099A1 (en) * 2001-01-10 2004-12-23 The Regents Of The University Of Michigan Amino ceramide-like compounds and therapeutic methods of use
CA2434028C (en) 2001-01-10 2010-11-09 The Regents Of The University Of Michigan Amino ceramide-like compounds and therapeutic methods of use
US7148251B2 (en) * 2001-01-10 2006-12-12 The Regents Of The University Of Michigan Amino ceramide-like compounds and therapeutic methods of use
US20020198240A1 (en) * 2001-01-10 2002-12-26 Shayman James A. Amino ceramide - like compounds and therapeutic methods of use
DK2266968T3 (da) * 2001-07-16 2013-04-08 Genzyme Corp Syntese af UDP-glucose: N-acylsphingosin-glucosyltransferase-hæmmere
US6835831B2 (en) * 2001-11-26 2004-12-28 Genzyme Corporation Diastereoselective synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
GB0229931D0 (en) 2002-12-21 2003-01-29 Astrazeneca Ab Therapeutic agents
JPWO2003057874A1 (ja) * 2001-12-28 2005-05-19 住友製薬株式会社 腎疾患の疾患マーカー及びその利用
HRP20040660B1 (hr) * 2002-01-22 2012-10-31 Warner-Lambert Company Llc 2-(PIRIDIN-2-ILAMINO)-PIRIDO[2,3-d]PIRIMIDIN-7-ONI
EP1336411A1 (en) 2002-02-14 2003-08-20 Academisch Medisch Centrum bij de Universiteit van Amsterdam Compositions and methods for improving enzyme replacement therapy of lysosomal storage diseases
JP2003238410A (ja) 2002-02-21 2003-08-27 Seibutsu Yuki Kagaku Kenkyusho:Kk インスリン抵抗性解除剤
US20060217560A1 (en) * 2002-04-29 2006-09-28 Shayman James A Amino ceramide-like compounds and therapeutic methods of use
US6916802B2 (en) * 2002-04-29 2005-07-12 Genzyme Corporation Amino ceramide-like compounds and therapeutic methods of use
WO2004006756A2 (en) 2002-07-17 2004-01-22 Biogen Idec Ma Inc. THERAPIES FOR RENAL FAILURE USING INTERFERON-β
WO2004007453A1 (en) 2002-07-17 2004-01-22 Oxford Glycosciences (Uk) Ltd Piperidinetriol derivatives as inhibitors of glycosylceramide synthase
WO2004078194A1 (en) 2003-02-28 2004-09-16 Intermune, Inc. Interferon drug therapy for the treatment of viral diseases and liver fibrosis
GB0313678D0 (en) * 2003-06-13 2003-07-16 Oxford Glycosciences Uk Ltd Novel compounds
AU2004283631A1 (en) 2003-10-29 2005-05-06 Genzyme Corporation Use of a deoxynojirimycin derivative or a pharmaceutically salt thereof
EP1528056A1 (en) * 2003-10-29 2005-05-04 Academisch Ziekenhuis bij de Universiteit van Amsterdam Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors
JP2007516294A (ja) 2003-12-23 2007-06-21 エムユーエスシー ファウンデーション フォー リサーチ ディベロップメント 炎症性の疾患または症状の予防および治療のための方法および組成物
GB0400812D0 (en) 2004-01-14 2004-02-18 Celltech R&D Ltd Novel compounds
EP1576894A1 (en) 2004-03-16 2005-09-21 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO The use of sphingolipids in the treatment and prevention of type 2 diabetes mellitus, insulin resistance and Metabolic Syndrome
DE602005026785D1 (de) 2004-03-16 2011-04-21 Tno Verwendung von sphingolipiden bei der behandlung und vorbeugung von typ-2-diabetes mellitus, insulinresistenz und metabolismussyndrom
AU2005240714B2 (en) 2004-05-07 2011-07-07 Merck Patent Gmbh GM3 synthase as a therapeutic target in microvascular complications of diabetes
WO2005123055A2 (en) 2004-06-14 2005-12-29 Musc Foundation For Research Development Methods for treating inflammatory disorders
CA2581173A1 (en) 2004-08-20 2006-03-02 The Johns Hopkins University Methods for treatment of angiogenesis
WO2006053043A2 (en) 2004-11-10 2006-05-18 Genzyme Corporation Methods of treating diabetes mellitus
HUE028654T2 (en) 2005-01-26 2016-12-28 Allergan Inc 3-aryl-3-hydroxy-2-aminopropionic amides, 3-heteroaryl-3-hydroxy-2-aminopropionic amides and related compounds having analgesic and / or immunostimulating activity
US8389472B2 (en) 2005-08-19 2013-03-05 Amylin Pharmaceuticals, Llc Exendin-4 to treat nonalcoholic steatohepatitis and nonalcoholic fatty liver disease
PT2032134E (pt) 2006-05-09 2015-10-07 Genzyme Corp Métodos de tratamento da doença do fígado gorduroso
WO2008011487A2 (en) 2006-07-19 2008-01-24 Allergan, Inc. L-benzyl-l-hydr0xy-2, 3-diamin0-propyl amines and 3-benzyl-3-hydroxy-2-amino-propionicacid amides for chronic pain
WO2008011478A2 (en) 2006-07-19 2008-01-24 Allergan, Inc. Methods for treating chronic pain using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds
GB0614947D0 (en) 2006-07-27 2006-09-06 Isis Innovation Epitope reduction therapy
TWI389895B (zh) 2006-08-21 2013-03-21 Infinity Discovery Inc 抑制ｂｃｌ蛋白質與結合夥伴間之交互作用的化合物及方法
CA2677485A1 (en) * 2007-02-09 2008-08-14 Irm Llc Compounds and compositions as channel activating protease inhibitors
EP2594565B1 (en) * 2007-05-31 2018-10-24 Genzyme Corporation 2-acylaminopropanol-type glucosylceramide synthase inhibitors
ES2660690T3 (es) * 2007-10-05 2018-03-23 Genzyme Corporation Método para tratar poliquistosis renales con derivados de ceramida
WO2009117150A2 (en) 2008-03-20 2009-09-24 Genzyme Corporation Method of treating lupus with ceramide derivatives
JP2011529500A (ja) 2008-07-28 2011-12-08 ジェンザイム コーポレーション 虚脱性糸球体症および他の糸球体疾患の処置のためのグルコシルセラミドシンターゼ阻害
CA2738768C (en) 2008-10-03 2017-10-31 Genzyme Corporation 2-acylaminopropoanol-type glucosylceramide synthase inhibitors

Similar Documents

Publication Publication Date Title
JP2012504608A5 (enExample)
JP2013537203A5 (enExample)
JP2016506960A5 (enExample)
JP2011519854A5 (enExample)
JP2009533410A5 (enExample)
JP2009535358A5 (enExample)
JP2008525416A5 (enExample)
JP2011529500A5 (enExample)
RU2011117028A (ru) Ингибиторы глюкозилцерамидсинтазы 2-ациламинопропанольного типа
JP2013504593A5 (enExample)
JP2014528466A5 (enExample)
JP2014521688A5 (enExample)
JP2016506961A5 (enExample)
JP2007517035A5 (enExample)
JP2017132814A5 (enExample)
JP2012236838A5 (enExample)
JP2007517044A5 (enExample)
JP2008195730A5 (enExample)
JP2014524441A5 (enExample)
RU2009102535A (ru) Производные карбамидов тропана, их получение и их применение в терапии
JP2014510774A5 (enExample)
MX2009009492A (es) Compuestos organicos biciclicos adecuados para el tratamiento de condiciones inflamatorias o alergicas.
JP2009530306A5 (enExample)
JP2008510828A5 (enExample)
JP2016506962A5 (enExample)